Does TAGRAXOFUSP-ERZS Cause Off label use? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Off label use have been filed in association with TAGRAXOFUSP-ERZS. This represents 5.3% of all adverse event reports for TAGRAXOFUSP-ERZS.
23
Reports of Off label use with TAGRAXOFUSP-ERZS
5.3%
of all TAGRAXOFUSP-ERZS reports
12
Deaths
6
Hospitalizations
How Dangerous Is Off label use From TAGRAXOFUSP-ERZS?
Of the 23 reports, 12 (52.2%) resulted in death, 6 (26.1%) required hospitalization, and 3 (13.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAGRAXOFUSP-ERZS. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does TAGRAXOFUSP-ERZS Cause?
Capillary leak syndrome (110)
Pyrexia (45)
Death (36)
Disease progression (33)
Thrombocytopenia (26)
Blood albumin decreased (24)
Acute kidney injury (23)
Weight increased (22)
Transaminases increased (21)
Tumour lysis syndrome (21)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TAGRAXOFUSP-ERZS Alternatives Have Lower Off label use Risk?
TAGRAXOFUSP-ERZS vs TAHOR
TAGRAXOFUSP-ERZS vs TALAZOPARIB
TAGRAXOFUSP-ERZS vs TALC
TAGRAXOFUSP-ERZS vs TALIGLUCERASE ALFA
TAGRAXOFUSP-ERZS vs TALIMOGENE LAHERPAREPVEC